Vir Biotechnology, Inc.
Total Trades
177
Buys
3
Sells
145
Largest Trade
N/A
Insiders
18
Institutional Funds
166
Inst. Value
$1M+
Activist Filings
17
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Ramasastry Saira | Director | GRANT | N/A | 6K | — | May 25, 2022 |
| Ramasastry Saira | Director | SELL | $15K–$50K | 2K | $23.82 | May 25, 2022 |
| SATO VICKI L | Director | SELL | $100K–$500K | 15K | $20.62 | May 10, 2022 |
| SATO VICKI L | Director | SELL | $100K–$500K | 18K | $20.90 | May 2, 2022 |
| HANLY ANN M. | CTO | SELL | $50K–$100K | 3K | $26.24 | Mar 31, 2022 |
| Virgin Herbert | EVP, Research & CSO | GRANT | N/A | 70K | — | Feb 25, 2022 |
| Virgin Herbert | EVP, Research & CSO | SELL | $15K–$50K | 1K | $30.00 | Feb 25, 2022 |
| Virgin Herbert | EVP, Research & CSO | EXERCISE | $1K–$15K | 1K | $1.53 | Feb 25, 2022 |
| Virgin Herbert | EVP, Research & CSO | SELL | $50K–$100K | 2K | $31.93 | Feb 22, 2022 |
| SCANGOS GEORGE A | President and CEO | SELL | $500K+ | 28K | $31.11 | Feb 22, 2022 |
| Rice Steven J. | Chief Administrati… | SELL | $50K–$100K | 2K | $31.93 | Feb 22, 2022 |
| Horn Howard | CFO | SELL | $50K–$100K | 2K | $31.93 | Feb 22, 2022 |
| Pang Phillip | Chief Medical Offi… | SELL | $100K–$500K | 8K | $31.69 | Feb 18, 2022 |
| Pang Phillip | Chief Medical Offi… | EXERCISE | $1K–$15K | 5K | $1.53 | Feb 18, 2022 |
| Virgin Herbert | EVP, Research & CSO | EXERCISE | $1K–$15K | 1K | $1.53 | Feb 9, 2022 |
| Virgin Herbert | EVP, Research & CSO | SELL | $15K–$50K | 1K | $33.94 | Feb 9, 2022 |
| Pang Phillip | Chief Medical Offi… | EXERCISE | $1K–$15K | 5K | $1.53 | Feb 4, 2022 |
| Pang Phillip | Chief Medical Offi… | SELL | $100K–$500K | 5K | $34.52 | Feb 4, 2022 |
| Virgin Herbert | EVP, Research & CSO | EXERCISE | $1K–$15K | 1K | $1.53 | Jan 27, 2022 |
| Virgin Herbert | EVP, Research & CSO | SELL | $15K–$50K | 1K | $32.46 | Jan 27, 2022 |
| Pang Phillip | Chief Medical Offi… | EXERCISE | $1K–$15K | 5K | $1.53 | Jan 20, 2022 |
| Pang Phillip | Chief Medical Offi… | SELL | $100K–$500K | 5K | $35.06 | Jan 20, 2022 |
| SATO VICKI L | Director | SELL | $500K+ | 15K | $37.39 | Jan 20, 2022 |
| Virgin Herbert | EVP, Research & CSO | EXERCISE | $1K–$15K | 1K | $1.53 | Jan 13, 2022 |
| Virgin Herbert | EVP, Research & CSO | SELL | $15K–$50K | 1K | $35.10 | Jan 13, 2022 |
| Pang Phillip | Chief Medical Offi… | SELL | $100K–$500K | 5K | $37.19 | Jan 7, 2022 |
| Pang Phillip | Chief Medical Offi… | EXERCISE | $1K–$15K | 5K | $1.53 | Jan 7, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 166 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 13.1M | $1M+ | SH |
| GSK plc | 8.6M | $1M+ | SH |
| STATE STREET CORP | 6.2M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 2.4M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 2.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $1M+ | SH |
| Aberdeen Group plc | 1.4M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 1.4M | $1M+ | SH |
| Hudson Bay Capital Management LP | 1.3M | $1M+ | SH |
| Candriam S.C.A. | 1.0M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 904K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 614K | $1M+ | SH |
| Clarius Group, LLC | 608K | $1M+ | SH |
| HRT FINANCIAL LP | 592K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 599K | $1M+ | SH |
| Ikarian Capital, LLC | 576K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 531K | $1M+ | SH |
| Alta Partners Management Company, L.P. | 510K | $1M+ | SH |
| PRINCIPAL FINANCIAL GROUP INC | 447K | $1M+ | SH |
| UBS Group AG | 396K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Mar 3, 2026
8.1%
12.9M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Feb 17, 2026
9.4%
13.1M shares
SC 13G/A · Apr 28, 2025
10.8%
14.8M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 18, 2024
4.1%
5.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.1%
12.3M shares
SVF Endurance (Cayman) Limited
SC 13G/A · Feb 13, 2024
12.4%
16.7M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Jan 24, 2024
5.1%
0 shares
SC 13G/A · Jan 23, 2024
12.5%
16.9M shares
SVF Endurance (Cayman) Limited
SC 13G/A · Feb 14, 2023
15.2%
20.3M shares
SC 13G/A · Jan 24, 2023
10.6%
14.1M shares
SC 13D/A · Sep 13, 2022
9.7%
12.9M shares
SC 13G · Sep 8, 2022
10.1%
13.4M shares
SC 13D/A · May 10, 2022
14.5%
18.9M shares
SC 13G/A · Feb 14, 2022
4.8%
6.3M shares
Capital International Investors 95-1411037
SC 13G/A · Feb 11, 2022
4.3%
5.6M shares
SC 13G/A · Feb 10, 2022
6.5%
8.6M shares
SC 13D/A · Jan 10, 2022
14.5%
18.9M shares